ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 354437 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 354437; 2) Community: the network communities that were significantly associated with the response to NSC 354437; 3) Molecule: the relationships between components within communities and NSC 354437; 4) MDR: the compounds that were significantly associated with the NSC 354437.

NSC Compound Enrichment Correlation
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.00180188182321727 0.36150434
NSC 23416 Null 0.00182957917645006 0.37601735
NSC 294846 Cinnoline, 4-nitro-, 1-oxide 0.00182957917645006 0.45489243
NSC 630608 Null 0.00182957917645007 0.44605688
NSC 634035 4-amino-3-iodo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.00182957917645007 0.6183522
NSC 654379 ANTINEOPLASTIC-654379 0.00182957917645007 0.29736124
NSC 673650 4-Piperidinone, 1-methyl-2,6-bis[(2-nitrophenyl)methylene]- 0.00182957917645007 0.49515672
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.00182957917645007 0.35276327
NSC 69852 1,4-Butanediamine, N,N'-bis(3-aminopropyl)-, tetrahydrochloride (8CI9CI) 0.00182957917645007 0.39030966
NSC 701748 Null 0.00182957917645007 0.3315792
Total:106  Current:10    [First] [Prev] [Next] [Last]